MITORX THERAPEUTICS

mitorx-therapeutics-logo

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

#People #Financial #Website #More

MITORX THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2016-01-01

Address:
Harwell, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.mitorxtherapeutics.com

Status:
Active

Total Funding:
0


Current Employees Featured

glyn-edwards_image

Glyn Edwards
Glyn Edwards Chairman @ MitoRx Therapeutics
Chairman
2022-02-01

Investors List

oxford-technology-management_image

Oxford Technology Management

Oxford Technology Management investment in Seed Round - MitoRx Therapeutics

longevitytech-fund_image

Longevitytech.fund

Longevitytech.fund investment in Seed Round - MitoRx Therapeutics

science-angel-syndicate_image

Science Angel Syndicate

Science Angel Syndicate investment in Seed Round - MitoRx Therapeutics

wren-capital_image

Wren Capital

Wren Capital investment in Seed Round - MitoRx Therapeutics

rainbow-seed-fund_image

UK Innovation & Science Seed Fund

UK Innovation & Science Seed Fund investment in Seed Round - MitoRx Therapeutics

the-fink-family-office_image

The Fink Family Office

The Fink Family Office investment in Seed Round - MitoRx Therapeutics

Official Site Inspections

http://www.mitorxtherapeutics.com Semrush global rank: 5.36 M Semrush visits lastest month: 1.56 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "MitoRx Therapeutics"

MitoRx Therapeutics - First-in-class mitochondrial โ€ฆ

Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. Mito Rx Therapeutics' first-in-class first-in-target platform โ€ฆSee details»

MitoWorld

MitoRx Therapeuticsโ€™ first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases, focusing internally on 3 rare indications and partnering โ€ฆSee details»

MitoRx Therapeutics - LinkedIn

MitoRx Therapeutics is a preclinical stage platform biotech developing a new category of innovative small molecule mitochondrial metabolic modulators for weight loss with muscle protection in ...See details»

MitoRx Therapeutics

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, โ€ฆSee details»

MitoRx Therapeutics - Crunchbase Company Profile & Funding

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.See details»

MitoRx Therapeutics - 2025 Company Profile - Tracxn

Apr 28, 2025 MitoRx Therapeutics - Developer of therapeutics for muscular dystrophy and neurodegenerative disorders. Raised a total funding of $5.03M over 2 rounds from 22 investors.See details»

MITORX THERAPEUTICS LIMITED overview - Find and update โ€ฆ

MITORX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โ€ฆSee details»

MitoRx Therapeutics - VentureRadar

"MitoRx aims to become a global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction. The company is a preclinical โ€ฆSee details»

MitoRx Therapeutics - Craft

MitoRx Therapeutics has 5 employees across 2 locations and $4 m in total funding,. See insights on MitoRx Therapeutics including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

About MitoRx Therapeutics - pharmiweb.jobs

Oct 8, 2024 At MitoRx our mission is to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction.See details»

Overview, News & Similar companies - ZoomInfo.com

View MitoRx Therapeutics (www.mitorxtherapeutics.com) location in Oxfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

MitoRx Therapeutics

Dec 13, 2023 MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative โ€ฆSee details»

Company of the Month: MitoRx - MedCity

May 30, 2022 MitoRx Therapeutics are doing ground-breaking work to create the ideal mitochondrial medicine. After forming their company in March 2021, the co-founders Dr Jon โ€ฆSee details»

MitoRx Therapeutics Expands Leadership Team with Strategic

Jan 9, 2025 OXFORD, United Kingdom, Jan. 09, 2025 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial โ€ฆSee details»

MitoRx Therapeutics 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for MitoRx Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Mitorx Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

For more information visit our website at www.mitorxtherapeutics.com and follow us on LinkedIn. About the University of ExeterThe University of Exeter is a Russell Group university that โ€ฆSee details»

MitoRx Therapeutics Company Information - Funding, Investors, โ€ฆ

Get information on funding, investors, industries, and more for MitoRx Therapeutics. See MitoRx Therapeutics company profile and funding data.See details»

MitoRx Therapeutics - VentureRadar

Founded at the Medical University of South Carolina, MitoChem Therapeutics was started by two scientists who saw an opportunity to focus on developing treatments to address the effects of โ€ฆSee details»

MitoRx Press Room

Apr 25, 2022 Check-in here for updates and press releases for MitoRx Therapeutics. Reversing mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegenerationSee details»

MitoRx Therapeutics - Halting the Progress of Degenerative โ€ฆ

Apr 26, 2022 MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt โ€ฆSee details»

linkstock.net © 2022. All rights reserved